在病态肥胖的非吸烟者中进行支气管扩展剂可逆性测试:一项比较研究 - - 关注点不多
Divya Balan1, Manish R Shetty1, Manu K Mohan1
1Department of Respiratory medicine, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
这封信质疑Fluticasone/salmeterol与salbutamol进行比较的发现的新性,并指出两者都符合可逆性基准. 这也引起了人们对将吸入性皮质类固醇与支气管扩展剂结合的担忧.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 艾哈迈德等人以前的一项研究. 弗卢蒂卡松/萨尔米特醇组合治疗与沙布塔摩尔相比较.
- 该研究得出的结论是,相比salbutamol,组合治疗增加了FEV1,FEV1%的预测,以及FEV1/FVC比率.
更多相关视频
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
